AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Sep 27, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2006.102749v1
97/11/1945    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, M. M.
Right arrow Articles by Weiss, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, M. M.
Right arrow Articles by Weiss, J. B.
Related Collections
Right arrow Health Policy
Right arrow Other Infections
Right arrow Government
November 2007, Vol 97, No. 11 | American Journal of Public Health 1945-1951
© 2007 American Public Health Association
DOI: 10.2105/AJPH.2006.102749


HEALTH POLICY AND ETHICS

Anthrax Vaccine and Public Health Policy

Martin Meyer Weiss, MD, Peter D. Weiss, MD and Joseph B. Weiss, MD

Martin Meyer Weiss is with the Veterans Administration, Sepulveda, Calif, and the School of Medicine, University of California, Los Angeles. Peter D. Weiss is with the School of Medicine, University of California, Los Angeles. Joseph B. Weiss is with the School of Medicine, University of California, San Diego.

Correspondence: Requests for reprints should be sent to Martin Meyer Weiss, MD, Veterans Administration, 16111 Plummer St, Sepulveda, CA 91343 (e-mail: martin.weiss{at}med.va.gov).

The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent.

There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine.

The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
M. A. K. Ryan, T. C. Smith, C. J. Sevick, W. K. Honner, R. A. Loach, C. A. Moore, and J. D. Erickson
Birth Defects among Infants Born to Women Who Received Anthrax Vaccine in Pregnancy
Am. J. Epidemiol., August 15, 2008; 168(4): 434 - 442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association